COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbCellera Biologics Inc. | COM | 00288U106 | 420,515 | 10,450,180 | SH | | SOLE | | 10,450,180 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 2,240,219 | 41,904,586 | SH | | SOLE | | 41,904,586 | 0 | 0 |
Acceleron Pharma Inc. | COM | 00434H108 | 2,870 | 22,430 | SH | | SOLE | | 22,430 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 641 | 147,996 | SH | | SOLE | | 147,996 | 0 | 0 |
Adaptive Biotechnologies Corporation | COM | 00650F109 | 22,451 | 379,682 | SH | | SOLE | | 379,682 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 52,988 | 9,830,877 | SH | | SOLE | | 9,830,877 | 0 | 0 |
ADC Therapeutics SA | SHS | H0036K147 | 45,394 | 1,418,107 | SH | | SOLE | | 1,418,107 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 26,838 | 3,410,106 | SH | | SOLE | | 3,410,106 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 958 | 164,605 | SH | | SOLE | | 164,605 | 0 | 0 |
Akero Therapeutics, Inc. | COM | 00973Y108 | 3,054 | 118,378 | SH | | SOLE | | 118,378 | 0 | 0 |
Albireo Pharma, Inc. | COM | 01345P106 | 15,472 | 412,466 | SH | | SOLE | | 412,466 | 0 | 0 |
Alector, Inc. | COM | 014442107 | 3,620 | 239,228 | SH | | SOLE | | 239,228 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,368,786 | 8,760,794 | SH | | SOLE | | 8,760,794 | 0 | 0 |
Aligos Therapeutics, Inc. | COM | 01626L105 | 44,517 | 1,610,000 | SH | | SOLE | | 1,610,000 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 30,626 | 1,535,149 | SH | | SOLE | | 1,535,149 | 0 | 0 |
Allakos Inc. | COM | 01671P100 | 99,995 | 714,250 | SH | | SOLE | | 714,250 | 0 | 0 |
Altimmune, Inc. | COM | 02155H200 | 21,257 | 1,884,451 | SH | | SOLE | | 1,884,451 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 136,880 | 27,991,761 | SH | | SOLE | | 27,991,761 | 0 | 0 |
AnaptysBio, Inc. | COM | 032724106 | 9,184 | 427,179 | SH | | SOLE | | 427,179 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 51,283 | 896,551 | SH | | SOLE | | 896,551 | 0 | 0 |
Arcus Biosciences, Inc. | COM | 03969F109 | 1,888 | 72,709 | SH | | SOLE | | 72,709 | 0 | 0 |
argenx SE | SPONSORED ADR | 04016X101 | 299,842 | 1,019,557 | SH | | SOLE | | 1,019,557 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 590,446 | 3,540,270 | SH | | SOLE | | 3,540,270 | 0 | 0 |
Assembly Biosciences, Inc. | COM | 045396108 | 9,326 | 1,541,418 | SH | | SOLE | | 1,541,418 | 0 | 0 |
Atreca, Inc. | CL A COM | 04965G109 | 57,054 | 3,532,760 | SH | | SOLE | | 3,532,760 | 0 | 0 |
Athira Pharma, Inc. | COM | 04746L104 | 27,618 | 806,367 | SH | | SOLE | | 806,367 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 19,501 | 1,410,064 | SH | | SOLE | | 1,410,064 | 0 | 0 |
Autolus Therapeutics plc | SPONSORED ADS | 05280R100 | 6,993 | 782,183 | SH | | SOLE | | 782,183 | 0 | 0 |
Axsome Therapeutics, Inc. | COM | 05464T104 | 63,452 | 778,834 | SH | | SOLE | | 778,834 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 3,015,126 | 11,668,897 | SH | | SOLE | | 11,668,897 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 879 | 249,123 | SH | | SOLE | | 249,123 | 0 | 0 |
BioAtla, Inc. | COM | 09077B104 | 28,058 | 825,000 | SH | | SOLE | | 825,000 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 94,584 | 12,695,818 | SH | | SOLE | | 12,695,818 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 665,505 | 7,589,294 | SH | | SOLE | | 7,589,294 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 9,822 | 226,988 | SH | | SOLE | | 226,988 | 0 | 0 |
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 4,831 | 209,131 | SH | | SOLE | | 209,131 | 0 | 0 |
Cabaletta Bio, Inc. | COM | 12674W109 | 7,942 | 636,363 | SH | | SOLE | | 636,363 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 94,895 | 13,713,195 | SH | | SOLE | | 13,713,195 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 40,663 | 656,710 | SH | | SOLE | | 656,710 | 0 | 0 |
Chiasma, Inc. | COM | 16706W102 | 3,228 | 742,133 | SH | | SOLE | | 742,133 | 0 | 0 |
Chinook Therapeutics, Inc. | COM | 16961L106 | 11,874 | 748,693 | SH | | SOLE | | 748,693 | 0 | 0 |
Constellation Pharmaceuticals, Inc. | COM | 210373106 | 3,304 | 114,735 | SH | | SOLE | | 114,735 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 8,699 | 616,520 | SH | | SOLE | | 616,520 | 0 | 0 |
Cymabay Therapeutics, Inc. | COM | 23257D103 | 16,607 | 2,893,276 | SH | | SOLE | | 2,893,276 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 38,289 | 14,614,264 | SH | | SOLE | | 14,614,264 | 0 | 0 |
Denali Therapeutics Inc. | COM | 24823R105 | 7,433 | 88,738 | SH | | SOLE | | 88,738 | 0 | 0 |
Dicerna Pharmaceuticals, Inc. | COM | 253031108 | 2,250 | 102,121 | SH | | SOLE | | 102,121 | 0 | 0 |
Evofem Biosciences, Inc. | COM | 30048L104 | 991 | 411,396 | SH | | SOLE | | 411,396 | 0 | 0 |
Five Prime Therapeutics, Inc. | COM | 33830X104 | 11,363 | 668,000 | SH | | SOLE | | 668,000 | 0 | 0 |
Frequency Therapeutics, Inc. | COM | 35803L108 | 30,200 | 856,507 | SH | | SOLE | | 856,507 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 70,668 | 2,024,876 | SH | | SOLE | | 2,024,876 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 25,819 | 495,573 | SH | | SOLE | | 495,573 | 0 | 0 |
Galapagos NV | SPONSORED ADR | 36315X101 | 1,107 | 11,180 | SH | | SOLE | | 11,180 | 0 | 0 |
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 575 | 184,927 | SH | | SOLE | | 184,927 | 0 | 0 |
Gamida Cell Ltd. | SHS | M47364100 | 12,990 | 1,548,314 | SH | | SOLE | | 1,548,314 | 0 | 0 |
Genetron Holdings Limited | ADS | 37186H100 | 6,374 | 455,306 | SH | | SOLE | | 455,306 | 0 | 0 |
Genfit SA | ADS | 372279109 | 71 | 14,720 | SH | | SOLE | | 14,720 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 39,861 | 920,375 | SH | | SOLE | | 920,375 | 0 | 0 |
Gossamer Bio, Inc. | COM | 38341P102 | 4,649 | 480,729 | SH | | SOLE | | 480,729 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 13,029 | 112,897 | SH | | SOLE | | 112,897 | 0 | 0 |
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 6,507 | 180,000 | SH | | SOLE | | 180,000 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 126,878 | 5,994,704 | SH | | SOLE | | 5,994,704 | 0 | 0 |
HOOKIPA Pharma Inc. | COM | 43906K100 | 7,768 | 700,481 | SH | | SOLE | | 700,481 | 0 | 0 |
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 43,825 | 599,110 | SH | | SOLE | | 599,110 | 0 | 0 |
Idera Pharmaceuticals, Inc. | COM PAR | 45168K405 | 16,914 | 4,608,786 | SH | | SOLE | | 4,608,786 | 0 | 0 |
IGM Biosciences, Inc. | COM | 449585108 | 277,663 | 3,144,892 | SH | | SOLE | | 3,144,892 | 0 | 0 |
Immatics N.V. | SHS | N44445109 | 19,476 | 1,805,025 | SH | | SOLE | | 1,805,025 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 2,783,337 | 31,999,741 | SH | | SOLE | | 31,999,741 | 0 | 0 |
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 1,107 | 522,360 | SH | | SOLE | | 522,360 | 0 | 0 |
Inflarx N.V. | COM | N44821101 | 4,307 | 856,228 | SH | | SOLE | | 856,228 | 0 | 0 |
Inozyme Pharma, Inc. | COM | 45790W108 | 2,208 | 106,999 | SH | | SOLE | | 106,999 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 71,773 | 2,156,001 | SH | | SOLE | | 2,156,001 | 0 | 0 |
Intellia Therapeutics, Inc. | COM | 45826J105 | 6,055 | 111,296 | SH | | SOLE | | 111,296 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 654,292 | 15,649,182 | SH | | SOLE | | 15,649,182 | 0 | 0 |
Iteos Therapeutics, Inc. | COM | 46565G104 | 5,085 | 150,346 | SH | | SOLE | | 150,346 | 0 | 0 |
IVERIC bio, Inc. | COM | 46583P102 | 9,716 | 1,406,037 | SH | | SOLE | | 1,406,037 | 0 | 0 |
Karuna Therapeutics, Inc. | COM | 48576A100 | 7,108 | 69,966 | SH | | SOLE | | 69,966 | 0 | 0 |
Kezar Life Sciences, Inc. | COM | 49372L100 | 729 | 139,676 | SH | | SOLE | | 139,676 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 49,469 | 2,799,577 | SH | | SOLE | | 2,799,577 | 0 | 0 |
Kymera Therapeutics, Inc. | COM | 501575104 | 121,471 | 1,959,211 | SH | | SOLE | | 1,959,211 | 0 | 0 |
Kodiak Sciences Inc. | COM | 50015M109 | 2,039,104 | 13,879,952 | SH | | SOLE | | 13,879,952 | 0 | 0 |
Krystal Biotech, Inc. | COM | 501147102 | 41,932 | 698,874 | SH | | SOLE | | 698,874 | 0 | 0 |
Leap Therapeutics, Inc. | COM | 52187K101 | 1,259 | 559,705 | SH | | SOLE | | 559,705 | 0 | 0 |
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 3,256 | 115,626 | SH | | SOLE | | 115,626 | 0 | 0 |
LogicBio Therapeutics, Inc. | COM | 54142F102 | 3,445 | 451,478 | SH | | SOLE | | 451,478 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 4,588 | 200,679 | SH | | SOLE | | 200,679 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 166,668 | 1,499,213 | SH | | SOLE | | 1,499,213 | 0 | 0 |
Mereo BioPharma Group plc | ADS | 589492107 | 21,588 | 6,030,293 | SH | | SOLE | | 6,030,293 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 35,717 | 2,037,469 | SH | | SOLE | | 2,037,469 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 309,645 | 1,409,784 | SH | | SOLE | | 1,409,784 | 0 | 0 |
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 11,302 | 647,313 | SH | | SOLE | | 647,313 | 0 | 0 |
Molecular Templates, Inc. | COM | 608550109 | 1,257 | 133,833 | SH | | SOLE | | 133,833 | 0 | 0 |
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 53,887 | 3,821,740 | SH | | SOLE | | 3,821,740 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 64,888 | 676,975 | SH | | SOLE | | 676,975 | 0 | 0 |
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 3,230 | 106,616 | SH | | SOLE | | 106,616 | 0 | 0 |
Novavax, Inc. | COM | 670002401 | 18,924 | 169,706 | SH | | SOLE | | 169,706 | 0 | 0 |
Nurix Therapeutics, Inc. | COM | 67080M103 | 58,820 | 1,788,921 | SH | | SOLE | | 1,788,921 | 0 | 0 |
Opthea Limited | SPONSORED ADS | 68386J208 | 37,107 | 3,308,705 | SH | | SOLE | | 3,308,705 | 0 | 0 |
Orchard Therapeutics plc | ADS | 68570P101 | 1,436 | 332,502 | SH | | SOLE | | 332,502 | 0 | 0 |
Ovid Therapeutics Inc. | COM | 690469101 | 2,208 | 955,690 | SH | | SOLE | | 955,690 | 0 | 0 |
Oyster Point Pharma, Inc. | COM | 69242L106 | 1,156 | 61,424 | SH | | SOLE | | 61,424 | 0 | 0 |
Pacific Biosciences of California, Inc. | COM | 69404D108 | 83,059 | 3,201,972 | SH | | SOLE | | 3,201,972 | 0 | 0 |
Passage Bio, Inc. | COM | 702712100 | 6,018 | 235,362 | SH | | SOLE | | 235,362 | 0 | 0 |
Prelude Therapeutics Incorporated | COM | 74065P101 | 723,988 | 10,118,636 | SH | | SOLE | | 10,118,636 | 0 | 0 |
Protagonist Therapeutics, Inc. | COM | 74366E102 | 28,954 | 1,436,192 | SH | | SOLE | | 1,436,192 | 0 | 0 |
Protara Therapeutics, Inc. | COM STK | 74365U107 | 4,834 | 199,671 | SH | | SOLE | | 199,671 | 0 | 0 |
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 27,688 | 223,976 | SH | | SOLE | | 223,976 | 0 | 0 |
Replimune Group, Inc. | COM | 76029N106 | 5,856 | 153,512 | SH | | SOLE | | 153,512 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 68,821 | 2,314,873 | SH | | SOLE | | 2,314,873 | 0 | 0 |
Sangamo Therapeutics, Inc. | COM | 800677106 | 13,379 | 857,339 | SH | | SOLE | | 857,339 | 0 | 0 |
Seagen Inc. | COM | 81181C104 | 8,278,767 | 47,269,424 | SH | | SOLE | | 47,269,424 | 0 | 0 |
Silverback Therapeutics, Inc. | COM | 82835W108 | 11,033 | 238,095 | SH | | SOLE | | 238,095 | 0 | 0 |
Sunesis Pharmaceuticals, Inc. | COM | 867328874 | 106 | 53,066 | SH | | SOLE | | 53,066 | 0 | 0 |
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 7,488 | 690,167 | SH | | SOLE | | 690,167 | 0 | 0 |
TCR2 Therapeutics Inc. | COM | 87808K106 | 3,430 | 110,888 | SH | | SOLE | | 110,888 | 0 | 0 |
Tricida, Inc. | COM | 89610F101 | 4,437 | 629,300 | SH | | SOLE | | 629,300 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 61,524 | 444,444 | SH | | SOLE | | 444,444 | 0 | 0 |
uniQure N.V. | SHS | N90064101 | 244 | 6,740 | SH | | SOLE | | 6,740 | 0 | 0 |
Vaxart, Inc. | COM | 92243A200 | 7,987 | 1,398,795 | SH | | SOLE | | 1,398,795 | 0 | 0 |
Verastem, Inc. | COM | 92337C104 | 21,607 | 10,144,039 | SH | | SOLE | | 10,144,039 | 0 | 0 |
Viking Therapeutics, Inc. | COM | 92686J106 | 2,049 | 363,980 | SH | | SOLE | | 363,980 | 0 | 0 |
Xencor, Inc. | COM | 98401F105 | 16,116 | 369,370 | SH | | SOLE | | 369,370 | 0 | 0 |
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 10,572 | 687,386 | SH | | SOLE | | 687,386 | 0 | 0 |
Zymeworks Inc. | COM | 98985W102 | 80,742 | 1,708,472 | SH | | SOLE | | 1,708,472 | 0 | 0 |
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 16,033 | 15,000,000 | PRN | | SOLE | | 15,000,000 | 0 | 0 |
Invitae Corporation | NOTE 2.0% 9/1/2024 | 46185LAB9 | 16,446 | 10,300,000 | PRN | | SOLE | | 10,300,000 | 0 | 0 |